Objective: Blood concentrations of eosinophils and monocytes are part of the complete blood count. Reference ranges for these concentrations during the neonatal period, established by very large sample sizes and modern methods, are needed for identifying abnormally low or high values.
Introduction
Normal values for hematological parameters are not generally available for neonates because blood is not drawn on healthy neonates to establish normal ranges. Instead, 'reference ranges' are used in neonatal hematology. [1] [2] [3] [4] [5] [6] These consist of the 5th to 95th percentile values assembled from large numbers of neonates with minimal pathology or with pathology not thought to be relevant to the laboratory parameter under study. Recent examples of their usefulness include the following: Reference ranges for erythrocyte indices 3 have enabled identifying neonates with hereditary spherocytosis on the basis of an elevated mean corpuscular hemoglobin concentration. 7 Reference ranges for platelet concentrations 4 have enabled a definition of neonatal thrombocytosis, 5 and defining altitude-appropriate reference ranges for blood neutrophil concentrations 6 has enabled more precise identification of neonates with neutrophilia. 8 Abnormal blood concentrations of eosinophils or monocytes can assist in identifying adults with various pathological conditions. 9, 10 Reference ranges from very large data sets are lacking for blood concentrations of eosinophils and monocytes during the neonatal period, particularly among the extremely low birth weight neonates who now populate most of the level III neonatal intensive care units. Therefore, we constructed reference ranges for eosinophils and monocytes of neonates from 22 to 42 weeks of gestation on the day of birth, and over the first 28 days after birth, using the databases of an 18-hospital system in the western United States.
Methods
Information was collected as a de-identified limited data set from archived Intermountain Healthcare records. The information collected was limited to that shown in the figures of this report. Blood concentrations of eosinophils and monocytes were abstracted electronically from complete blood counts (CBCs) obtained on neonates with a date of birth from 1 January 2002 through 31 May 2009. Values were excluded if a diagnosis was identified anywhere in the electronic record of infection (bacterial, viral, fungal or protozoal) or necrotizing enterocolitis (NEC). The data fields used to identify infection or NEC were International Classification of Disease-Ninth Revision, Case Mix (the billing, coding and financial data mart used by Intermountain Healthcare) and EVOX (the extended Vermont-Oxford database). Blood samples were run on a Beckman Coulter LH750 (Fullerton, CA, USA), which is the instrument present in all Intermountain Healthcare Hospitals that have a level III neonatal intensive care unit. 11 Gestational age was determined by obstetrical assignment unless this was changed by the neonatal examination.
The program used for data collection was a modified subsystem of 'clinical workstation'. Clinical workstation is a web-based electronic medical record application that stores demographic and clinical information, such as history, physical examination results, laboratory data, problem lists and discharge summaries. The 3M Company (Minneapolis, MN, USA) approved the structure and definitions of all data points for use within the program. The data were collected from the electronic medical record, laboratory systems and case mix. Data were managed and accessed by authorized data analysts. Descriptive statistics were calculated using Statit (Corvallis, OR, USA). Means, 5 and 95% confidence intervals were used to express the data. The Intermountain Healthcare institutional review board approved the study as a de-identified, data only investigation not requiring written consent of the individuals.
Results
The absolute numbers of eosinophils and monocytes (cells ml -1 blood) were electronically retrieved from 96 162 CBCs obtained from neonates with gestational ages at birth ranging from 22 to 42 weeks; 32 971 of these were from patients in which infection or NEC was listed in one or more data-marts, and therefore these samples were not included in the reference range. Thus, the number of CBC on which the reference range was constructed was 63 371. The exact number of patients at each gestational age contributing data to the reference range is shown in Figure 1 .
The mean values for eosinophils increased approximately linearly between 22 and 42 weeks of gestation, as did the 5 and 95% values. The reference range for eosinophils at 40 weeks of gestation was 140 to 1300 ml -1 (mean 550 ml
; Figure 2 ). Similarly, the mean values for monocytes increased approximately linearly over this interval with a reference range at 40 weeks of 300 to 3300 ml -1 (mean 1400 ml -1 ; Figure 3 ). Over the first 4 weeks after birth, no appreciable change was observed in 5% limit and mean eosinophil count, with a slight increase in the 95% limit to approximately 1550 ml -1 by week 4 ( Figure 4) . A slight increase in mean monocyte count occurred over the first 2 weeks ( Figure 5 ).
Discussion
Eosinophils are effector cells involved in allergic and nonallergic inflammatory conditions. Circulating eosinophils are derived from myelocytic progenitors within both the marrow and extramedullary sites. After exiting the site of production and entering the blood, eosinophils circulate for approximately 1 day or so (T 1/2 18 h) after which they transmigrate to tissues, primarily in the gastrointestinal tract, in which they produce cytokines and chemokines. 10, 12 The physiological function of eosinophils is still somewhat enigmatic, but clearly they are part of a network of cells involved in asthma, allergy, helminthiases and inflammation.
Monocytes are part of the reticuloendothelial system, which is composed of granulocytic precursors, circulating monocytes and 
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9 Similar to other granulocytes, monocytes generally reside in the blood for <1 day (T 1/2 8.4 h), after which they transmigrate to tissues and become mononuclear phagocytes in the lung, kidney, peritoneum, gastrointestinal tract or reproductive tract, or become Langerhans cells, Kupffer cells, microglial cells or osteoclasts.
Several pathological conditions in neonates are associated with eosinophilic tissue infiltration, and generally these conditions are accompanied by blood eosinophilia. However, lacking reference ranges for eosinophil blood concentrations in neonates has created a problem of imprecision in defining eosinophilia in these neonates. 13 The conditions include erythema toxicum neonatorum, 14, 15 neonatal eosinophilic pustulosis 16, 17 and chronic respiratory inflammation due to Chlamydia trachomatis, 18 respiratory syncitial virus 19 or bronchopulmonary dysplasia. [20] [21] [22] [23] Other inflammatory conditions associated with eosinophilia are neonatal eosinophilic esophagitis, 24 eosinophilic colitis, 22 subcutaneous fat necrosis with eosinophilic granules, 25 a variety of infections, NEC and after erythrocyte transfusion. 26 Gibson et al.
27
reported elevated eosinophil counts among preterm infants corresponding with the time when weight gain was established.
Whether blood eosinophil counts are actually above the reference range in patients with any of these conditions can now be determined. Monocytosis has been observed in critically ill preterm infants, although the exact mechanisms underlying this response remain unclear. Rajadurai et al. 28 detected monocytosis, which they defined as an absolute monocyte count of >1700 ml exogenous stimuli, including drugs and foreign protein infusions. Monocytosis has been reported in neonates with intrauterine infections such as candidiasis and syphilis, although many of these infants had an increase in all leukocyte lineages. 29, 30 Monocytosis is occasionally noted in neutropenic infants. 31, 32 In our cohort, blood monocytes increased as a function of gestational age. This is consistent with the kinetic information from human fetal studies showing a maturational increase in the number of monocyte precursors. Monocytes constitute 2 to 4% of all hemic cells during the first trimester, 3 to 7% at 30 weeks and they continue to increase through the third trimester. 33, 34 Monocyte counts remain low in fetal blood until the fifth month of gestation and increase gradually once the marrow becomes the predominant site of hematopoiesis. 34, 35 Our reference range for monocyte concentrations in term infants was 300 to 3300 ml -1 , which is wider than the ranges reported by Kato 36 (1340 to 2200 ml -1 ) but is comparable to the data from Xanthou 37 (300 to 2100 ml -1 ). However, unlike the previous studies that showed highest monocyte counts during the first 24 h after birth, monocyte concentrations in our cohort increased during the first 2 weeks before beginning a downward trend in the third postnatal week. The use of automated cell counters has allowed more consistency in the enumeration of monocytes; immature large granular lymphocytes and neutrophil precursors at the myelocyte/metamyelocyte stage can be difficult to distinguish from monocytes on the basis of morphological criteria. 38 In some of the early studies, enumeration of these immature cells as monocytes may also have contributed to the marked but transient monocytosis noted during the early neonatal period.
In constructing neonatal reference ranges, data are generally omitted from patients with pathology relevant to the laboratory parameter under study. For instance, in establishing reference ranges for blood neutrophils, patients with infections are generally eliminated, because infection sometimes results in abnormal blood neutrophil counts. 6 In our present report, we removed patients with a discharge diagnosis of infection or NEC, but we did not remove those with other conditions that might influence eosinophil or monocyte concentrations. For instance, it is not clear whether we should have removed data from neonates with intrauterine growth retardation, multiple anomalies or various syndromes, because it is not known whether their eosinophil or monocyte counts are often abnormal. Now that we have a reference range with which to work, additional study is needed regarding groups that fall outside the range. We maintain that the present report is a useful step in that process, providing a definition of the expected values so that values higher or lower than expected can be flagged for further evaluation.
Before the present study, it was not clear whether abnormally low concentrations of eosinophils or monocytes could be identified. Specifically, it was not clear whether a result of zero per ml was within the reference range. 39 The present findings indicate that zero is not generally within the reference range, with the exception of eosinophils in neonates of <24 weeks of gestation. Therefore, neonates with a persistent eosinophil or monocyte count of zero should be considered to have an abnormality. In addition to any clinical utility of these reference ranges, we hope that the finding of a gradual increase in blood concentration of eosinophils and monocytes between week 22 and term will interest developmental biologists. Surely, the gradual but steady increase in the circulating concentrations of these cells indicates the relevance of roles that they have in human developmental biology.
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